Fulltext available Open Access
DC FieldValueLanguage
dc.contributor.advisorReintjes, Ralf-
dc.contributor.authorSoltani, Mahdis
dc.date.accessioned2020-09-29T12:03:51Z-
dc.date.available2020-09-29T12:03:51Z-
dc.date.created2007
dc.date.issued2007-05-10
dc.identifier.urihttp://hdl.handle.net/20.500.12738/6209-
dc.description.abstractVaricella is the most frequent vaccine preventable disease of childhood inGermany. Though usually mildly proceeding severe complications may occur, particularlyamong pregnant women, neonates, adults and the immunocompromised. Later in life 10-20% are afflicted by herpes zoster (HZ) through reactivation of the dormant varicella zostervirus (VZV). With regard to >750 000 varicella cases annually and consequent societal costs Germany has introduced VZV immunization into the routine childhood vaccination schedule in July 2004. As this recommendation is a matter of controversial discussion wereconsidered the underlying data in order to revise it. The success of a universal vaccination recommendation depends on several factors including disease burden, availability of a safe and effective vaccine, cost effectiveness of the vaccination and public perception. Such a programme should rashly achieve high and sustained levels of coverage. Concerning varicella vaccine there are certain issues of controversy which should be considered. Potential harm that may occur as a result of vaccination includes immediate adverse reactions, transmission of varicella from vaccinees, an increased risk of zoster, and a shift in varicella cases to an older age group (and hence more severe disease), waning immunity with time after vaccination especially with a lack of the boosting effect of wild-type virus circulation (95). Furthermore, introducing universal vaccination for children necessitates disease surveillance and modifications of the recommendation as needed. The epidemiology of herpes zoster must be tracked as well as varicella disease trends. The objective of this paper is to review the universal varicella vaccination recommendation in Germany and the underlying data.en
dc.language.isoenen
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/-
dc.subjectChildhood vaccinationen
dc.subjectGermanyen
dc.subject.ddc610 Medizin, Gesundheit
dc.titleRoutine childhood vaccinatio in Germany - well-founded?en
dc.typeThesis
openaire.rightsinfo:eu-repo/semantics/openAccess
thesis.grantor.departmentDepartment Gesundheitswissenschaften
thesis.grantor.placeHamburg
thesis.grantor.universityOrInstitutionHochschule für angewandte Wissenschaften Hamburg
tuhh.contributor.refereePebody, Richard-
tuhh.gvk.ppn528712586
tuhh.identifier.urnurn:nbn:de:gbv:18302-reposit-62114-
tuhh.note.externpubl-mit-pod
tuhh.note.intern1
tuhh.oai.showtrueen_US
tuhh.opus.id216
tuhh.publication.instituteDepartment Gesundheitswissenschaften
tuhh.type.opusMasterarbeit-
dc.subject.gndImpfung
dc.subject.gndKind
dc.subject.gndVarizellen-Virus
dc.type.casraiSupervised Student Publication-
dc.type.dinimasterThesis-
dc.type.drivermasterThesis-
dc.type.statusinfo:eu-repo/semantics/publishedVersion
dc.type.thesismasterThesis
dcterms.DCMITypeText-
tuhh.dnb.statusdomain-
item.creatorOrcidSoltani, Mahdis-
item.fulltextWith Fulltext-
item.advisorGNDReintjes, Ralf-
item.grantfulltextopen-
item.openairetypeThesis-
item.languageiso639-1en-
item.creatorGNDSoltani, Mahdis-
item.openairecristypehttp://purl.org/coar/resource_type/c_46ec-
item.cerifentitytypePublications-
Appears in Collections:Theses
Files in This Item:
File Description SizeFormat
med_y_201anh.pdf240.95 kBAdobe PDFView/Open
med_y_201.pdf294.78 kBAdobe PDFView/Open
Show simple item record

Page view(s)

88
checked on Aug 8, 2022

Download(s)

27
checked on Aug 8, 2022

Google ScholarTM

Check

Note about this record

Export

Items in REPOSIT are protected by copyright, with all rights reserved, unless otherwise indicated.